The next chapter for group B meningococcal vaccines

The next chapter for group B meningococcal vaccines

The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...

Descripció completa

Dades bibliogràfiques
Autors principals:	Wang, N, Pollard, A
Format:	Journal article
Idioma:	English
Publicat:	Taylor and Francis 2017

Ítems similars

Group B meningococcal vaccine science and policy
per: Drysdale, SB, et al.
Publicat: (2015)

Group B meningococcal vaccine: Recommendations for UK use
per: Pollard, A, et al.
Publicat: (2014)

Group B meningococcal vaccine: recommendations for UK use.
per: Pollard, A, et al.
Publicat: (2014)

Four component meningococcal capsular Group B vaccine in preterm infants.
per: Sadarangani, M, et al.
Publicat: (2017)

Meningococcal vaccines.
per: Rüggeberg, J, et al.
Publicat: (2004)

Meningococcal vaccines.
per: Collins, C, et al.
Publicat: (2002)

Meningococcal vaccines.
per: Bethell, D, et al.
Publicat: (2002)

Serogroup B meningococcal vaccines-an unfinished story.
per: Sadarangani, M, et al.
Publicat: (2010)

The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
per: Rollier, C, et al.
Publicat: (2014)

Quadrivalent meningococcal conjugate vaccines
per: Pace, D, et al.
Publicat: (2009)

Quadrivalent meningococcal conjugate vaccines.
per: Pace, D, et al.
Publicat: (2009)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
per: Rivero-Calle I, et al.
Publicat: (2019-10-01)

Vaccines for prevention of meningococcal disease.
per: Pollard, A, et al.
Publicat: (2000)

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
per: Dold, C, et al.
Publicat: (2023)

Challenges and progress in the development of a serogroup B meningococcal vaccine.
per: Lewis, S, et al.
Publicat: (2009)

Gonococcal Vaccine Development: Lessons from Group B Meningococcal Vaccines
Publicat: (2017-08-01)

Meningococcal meningitis presenting postinfant group B meningococcal immunisation
per: So, N, et al.
Publicat: (2018)

Safety of meningococcal group B vaccination in hospitalised premature infants
per: Kent, A, et al.
Publicat: (2018)

The epidemiology of meningococcal disease and the impact of vaccines.
per: Khatami, A, et al.
Publicat: (2010)

Meningococcal disease and vaccination in North America.
per: Pollard, A, et al.
Publicat: (2001)

Reconsideration of the use of meningococcal polysaccharide vaccine.
per: Granoff, D, et al.
Publicat: (2007)

Meningococcal polysaccharide-protein conjugate vaccines.
per: Snape, MD, et al.
Publicat: (2005)

Impact of meningococcal group B OMV vaccines, beyond their brief
per: Helen Petousis-Harris
Publicat: (2018-05-01)

Development of group B meningococcal vaccine: a progress review
per: Wei ZHAO, et al.
Publicat: (2022-08-01)

Global epidemiology of meningococcal disease and vaccine efficacy
per: Pollard, A
Publicat: (2004)

Global epidemiology of meningococcal disease and vaccine efficacy.
per: Pollard, A
Publicat: (2004)

Emerging clinical experience with vaccines against group B meningococcal disease
per: Wilkins, A, et al.
Publicat: (2017)

Vaccine prevention of meningococcal disease, coming soon?
per: Morley, S, et al.
Publicat: (2001)

Vaccine prevention of meningococcal disease, coming soon?
per: Morley, S, et al.
Publicat: (2001)

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
per: Sadarangani, M, et al.
Publicat: (2017)

Enter B and W: two new meningococcal vaccine programmes launched.
per: Ladhani, S, et al.
Publicat: (2016)

Enter B and W: two new meningococcal vaccine programmes launched
per: Ladhani, S, et al.
Publicat: (2015)

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.
per: James B Wing, et al.
Publicat: (2012-01-01)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine
per: Weissmueller, N, et al.
Publicat: (2017)

Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
per: F. Marc LaForce, et al.
Publicat: (2018-05-01)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
per: O'Connor, D, et al.
Publicat: (2020)

Meningococcal disease
per: Pollard, A
Publicat: (2018)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
per: Daniel O’Connor, et al.
Publicat: (2020-11-01)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
per: Read, R, et al.
Publicat: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
per: Read, R, et al.
Publicat: (2014)